{"id":108116,"date":"2024-05-14T15:18:14","date_gmt":"2024-05-14T15:18:14","guid":{"rendered":"https:\/\/www.atlasrleye.com\/?page_id=108116"},"modified":"2024-06-17T13:38:53","modified_gmt":"2024-06-17T13:38:53","slug":"clinical-case-11","status":"publish","type":"page","link":"https:\/\/www.atlasrleye.com\/en\/proliferative-diabetic-retinopathy-in-type-1-diabetes\/clinical-case-11\/","title":{"rendered":"Clinical Case 11"},"content":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Diabetic%20Retinopathy|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” add_icon=”true” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 1 Diabetes – Clinical Case 11″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” css=”” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-1-diabetes%2F|title:PROLIFERATIVE%20DIABETIC%20RETINOPATHY%20IN%20TYPE%201%20DIABETES|”]

<\/div>[\/vc_column][\/vc_row][vc_row][vc_column]
<\/div>
<\/div>[\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”107804″ img_size=”medium” alignment=”center” onclick=”link_image” css=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

Proliferative diabetic retinopathy (RLE) in a 43-year-old patient. The left eye presents with tractional retinal detachment and fibrovascular membranes in the nasal retina. The OD has silicone oil in the vitreous cavity and fibrovascular membranes. BCVA: 20\/400 RE; 20\/50 LE. HbA1c=10,5%.<\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”107815″ img_size=”medium” alignment=”center” onclick=”link_image” css=””][\/vc_column_inner][vc_column_inner width=”1\/2″][vc_column_text css=””]<\/p>\n

15 years after surgery. Laser photocoagulation treatment. HbA1c=6,1%. BCVA: NPL RE; 8\/10 LE. <\/span><\/p>\n

[\/vc_column_text][\/vc_column_inner][\/vc_row_inner][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n

Evaluations
\n<\/span><\/h3>\n

[\/vc_column_text][vc_tta_accordion active_section=”99″ no_fill=”true” collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”1st Evaluation – 30 04 2009″ tab_id=”1671795919289-748acc60-ba6d”][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107602,107606″ img_size=”300×206″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107610,107614,107618,107622,107582,107586,107590,107594″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

LE: tractional retinal detachment. RE: silicone oil in the vitreous cavity; areas of fibrosis.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107598″ img_size=”280×206″ css=”.vc_custom_1715699868693{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”2nd Evaluation – postoperative – 25 05 2009″ tab_id=”1671731979894-a1c6e53a-7f91″][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

LE after catarat surgery and RE with total cataract.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107638,107642″ img_size=”320*206″ css=”.vc_custom_1715788493335{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n

\n

OCT, 2 weeks after surgery (LE): phacoemulsification with IOL implantation;VPP vitrectomy and fibrovascular membrane peeling. HbA1c 6.6%.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107646,107650,107626,107630″ img_size=”307×110″ css=”.vc_custom_1715788658542{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107634″ img_size=”251×206″ css=”.vc_custom_1715788437882{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”3rd Evaluation – 14 05 2012″ tab_id=”1671796344565-355b72b4-8691″][vc_row_inner][vc_column_inner width=”2\/3″][vc_column_text css=””]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

LE: intraocular lens opacified by CaCO3 deposits.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107666,107670″ img_size=”320×206″ css=”.vc_custom_1715788916208{margin-top: -30px !important;}”][\/vc_column_inner][vc_column_inner width=”1\/3″][vc_column_text css=””]<\/p>\n

\n
\n

Visumetry<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107678″ img_size=”400*206″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107686,107654,107658,107662″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107674,107682″ img_size=”251×206″ css=””][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”4th Evaluation – postoperative – 22 05 2012″ tab_id=”1671796840330-e71e9361-6fd6″][vc_row_inner][vc_column_inner width=”2\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107714,107698″ img_size=”193×206″ css=””][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107702″ img_size=”193×206″ css=””][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107694″ img_size=”193×206″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

One week after intraocular lens replacement.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107706″ img_size=”320×206″ css=”.vc_custom_1715789817232{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107718,107690″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

Colour retinography<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107710″ img_size=”251×206″ css=””][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”5th Evaluation – 15 01 2020″ tab_id=”1671798147691-bfbf7c13-be8d”][vc_row_inner][vc_column_inner width=”2\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107742,107734″ img_size=”193×206″ css=””][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107730″ img_size=”193×206″ css=””][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Red-free<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107726″ img_size=”193×206″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107750,107754,107758,107722″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n

\n

BCVA: NPL RE; 8\/10 LE. Laser photocoagulation treatment. <\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107738,107746″ img_size=”251×206″ css=”.vc_custom_1715790313620{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][vc_tta_section i_icon_fontawesome=”far fa-calendar-alt” add_icon=”true” title=”6th Evaluation – 03 04 2024″ tab_id=”1671798295597-df6d0c8d-714a”][vc_row_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Autofluorescence<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107783″ img_size=”193×206″ css=””][\/vc_column_inner][vc_column_inner width=”1\/4″][vc_column_text]<\/p>\n

\n
\n

Infrared<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107771″ img_size=”193×206″ css=””][\/vc_column_inner][vc_column_inner width=”2\/4″][vc_column_text css=””]<\/p>\n

\n
\n

Anterior Segment Photo<\/p>\n

\n

BCVA: NPL RE; 8\/10 LE. HbA1c=6,1%.<\/span><\/p>\n<\/div>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107775″ img_size=”320×206″ css=”.vc_custom_1715790551574{margin-top: -30px !important;}”][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text]<\/p>\n

\n
\n

OCT (B-Scan) longitudinal<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107788,107793,107762,107766″ img_size=”307×110″ css=””][\/vc_column_inner][\/vc_row_inner][vc_row_inner][vc_column_inner][vc_column_text css=””]<\/p>\n

\n
\n

Colour retinography<\/p>\n

[\/vc_column_text][vc_gallery type=”image_grid” images=”107778″ img_size=”251×250″ css=””][\/vc_column_inner][\/vc_row_inner][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<\/p>\n<\/div>\n<\/div>\n

[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_custom_heading text=”DIABETIC RETINOPATHY” font_container=”tag:h5|font_size:22px|text_align:center|color:%23000000″ use_theme_fonts=”yes” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fretinopatia-diabetica%2F|title:Diabetic%20Retinopathy|”][vc_text_separator title=”” i_icon_fontawesome=”fas fa-eye” i_color=”custom” i_size=”lg” color=”custom” border_width=”8″ css=”.vc_custom_1637080776101{margin-bottom: -5px !important;}” add_icon=”true” accent_color=”#bababa” i_custom_color=”#bababa”][vc_custom_heading text=”Proliferative Diabetic Retinopathy in Type 1 Diabetes – Clinical Case 11″ font_container=”tag:h1|text_align:center|color:%235f1b52″ use_theme_fonts=”yes” css=”” link=”url:https%3A%2F%2Fwww.atlasrleye.com%2Fen%2Fproliferative-diabetic-retinopathy-in-type-1-diabetes%2F|title:PROLIFERATIVE%20DIABETIC%20RETINOPATHY%20IN%20TYPE%201%20DIABETES|”][\/vc_column][\/vc_row][vc_row][vc_column][\/vc_column][\/vc_row][vc_row gap=”35″ equal_height=”yes”][vc_column width=”1\/2″][vc_row_inner][vc_column_inner width=”1\/2″][vc_single_image image=”107804″ img_size=”medium” […]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":75353,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-108116","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/108116","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/comments?post=108116"}],"version-history":[{"count":16,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/108116\/revisions"}],"predecessor-version":[{"id":108529,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/108116\/revisions\/108529"}],"up":[{"embeddable":true,"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/pages\/75353"}],"wp:attachment":[{"href":"https:\/\/www.atlasrleye.com\/en\/wp-json\/wp\/v2\/media?parent=108116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}